Submissions

Online Submissions

Already have a Username/Password for SALAMAT IJTIMAI (Community Health)?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

The journal accepts manuscripts for publication as the following types:

  • Editorial: Editorials are usually written on invitation by the Editor-in-Chief, regarding articles scheduled to appear in the corresponding issue or describing issues of special importance.
  • Letters: Letters are accepted for publication including those that may wish to comment on articles in previous issues, or those that contain additional considerations worth of notice.
  • Original Articles: The journal accepts papers derived from original research in different fields of study as the scope of the journal allows.
  • Review Articles: Reviews are accepted for publication in different fields of study as the scope of the journal allows.
  • Community Case Reports: Interesting or educational cases are accepted for presentation in the Community Case Report section.
  • Policy Notes or Appraisal: Appraising current policy and programs in different fields of health.
  • Community Intervention Technique: New Community Intervention techniques can be arranged to be presented, accompanied by a complete description of the method, outcomes and a discussion.
  • News: News is written by the editors or selected authors, but any information which may be of interest to researchers of community medicine and public health sciences will be taken into consideration for publication.

Manuscripts should include the following sections:

a) Title Page

The title page should include:

(1) the manuscript type (e.g., original article, community case report, etc.);

(2) the complete manuscript title;

 (3) authors' full names (listed as first name, middle initial and last name, with the last name underlined);

(4) highest academic degrees and affiliations of the authors;

(5) the name of the corresponding author, academic rank or position, complete postal address, fax number, telephone number, and e-mail address;

(6) a running title of no more than 40 characters (not counting space).

b) Abstract

The abstract should be no longer than 250 words. Abstracts for original articles should be structured using the following headings: Background, Methods, Results, and Conclusion.

Abstracts for community case reports and challenging cases should be structured as: Background, Case Report, and Conclusion. Abstracts for review articles and community Intervention technique submissions should be unstructured, summarizing the main points of interest. No abstracts are required for editorials, policy notes or appraisal, news and letters.

The use of abbreviations and acronyms in the abstract should be limited. The abstract should be composed to stand alone and convey the message independent of the main text.

A number of 3-6 keywords should be included after the abstract, preferably using MeSH terms for biomedical terminology.

c) Main Text

Original articles should be structured under 
the following main headings: IntroductionMethodsResults, and Discussion.

Community Case reports and challenging cases should include IntroductionCase Report, and Discussion sections.

Community Intervention techniques should be presented with IntroductionTechnique, Results (to report the outcomes) andDiscussion headings.

Review articles are subject to higher versatility, and may include headings as required, but generally include Introduction, Methods, Results and Conclusion headings as well as headings the author(s) consider necessary.

Acknowledgements may be added under a separate heading at the end of the main text.

These main headings should be emphasized in bold face type. Additional subheadings can be used in each section, accentuated throughout the text with italic face type.

d) References

Cite only published work as references. Personal communication and unpublished data should be incorporated into the text without any reference number. Cite references within the text with superscript numerals. Assign numbers in the order that references are first cited within the text. 
In the reference section, list the cited works in numerical order. Abbreviate journal names according to Index Medicus. For references with more than 6 authors, cite the names of the first 6 followed by et al.

Using Vancouver method, reference to journal articles should include: authors, title, journal name (as abbreviated in Index Medicus), year, volume number and pages. References to books should include: authors of chapter and chapter title (if any), authors or editors of book, title of book, edition, city of publication, publishing company, year, and page numbers (for limited reference to chapters within books). The following examples demonstrate correct reference style:

  • Journal Article: Gravel JS, Roberts JE, Roush J, Grose J, Besing J, Burchinal M, et al. Early otitis media with effusion, hearing loss, and auditory processes at school age. Ear Hear. 2006 ;27(4):353-68.
  •  Book Chapter: Thompson J. Proliferative vitreoretinopathy. In: Ryan SJ (ed). Retina. 3rd ed. St. Louis: Mosby; 2001: 1309-1349.
  • Book: Bradley WJ. Neurology in clinical practice. 4th ed. Philadelphia: Butterworth-Heinemann; 2004.
  • Conference, Congress or Seminar: Blumenkranz MS. New developments in diabetic vitrectomy. The Vitreoretinal Frontier, Dallas, Texas, USA. November 6-7, 1992.
  • Website: Bureau of Health Promotion, Department of Health, R.O.C. (Taiwan). Available from: www.bhp.doh.gov.tw. Accessed January 25, 2010.

3. Tables and Figures

Tables and figures should be labeled sequentially, numbered and cited in the text. They should be referred to specifically in the text of the paper but should not be embedded within the text.

a) Tables

Each table should be double-spaced on a separate sheet at the end of the manuscript and numbered consecutively in the order of first citation in the text. Use the word processor to create the tables and avoid submitting them separately as picture files. Titles and footnotes should appear above and below the tables, respectively, on the corresponding pages. The footnotes within the table must be indicated with superscript lowercase letters.

b) Figures

Figures can include diagrams created by the word processor (managed as the tables, appearing at the end of the manuscript with appropriate titles and numbering), or preferably, can be submitted as images in separate files. Images must be submitted in .jpg or .tiff formats with sufficient quality and a resolution of at least 300 dpi.

The file names must be numbered corresponding to their appearance in the text and the legends should be included on a separate page of the manuscript file.

4. Style

All manuscripts should be written in clear and grammatically correct English. Manuscripts must be submitted in .doc or .rtf formats, preferably using Microsoft Word as the word processor. A single 12-point font should be used for the whole manuscript. The text should be double spaced in a single column. Do not break or hyphenate words at the end of the line. Keep formatting minimal and use the word processor's options only to justify or center text, or present text as bold, italics, underline, subscripts, and superscripts. Begin each of the following on a new page: Title Page, Abstract and Keywords, Main Text, Acknowledgments, References, Tables and Figure legends.

Quantitative data may be reported in the units used in the original measurement, but the equivalent in SI units must be mentioned.

Abbreviations and Symbols

Use standard abbreviations and symbols and avoid creating new abbreviations. Avoid abbreviations in the title and unusual abbreviations in the abstract. Use an abbreviation only if the term is repeated several times in the paper. Write out the full term the first time it appears, followed by the abbreviation in parentheses. Thereafter, employ the abbreviation alone. Standard units of measurement can be abbreviated without explanation (e.g., mmHg, PD, D, etc).

5. Cover Letter

The authors must warrant that they have participated sufficiently in the work described to justify authorship and that the article is original, not under consideration for publication by another journal and has not been published previously. The authors must accept full responsibility for the conduct of the study, state that they had access to the data and jointly controlled and agreed on the decision to publish.

The authors should also state if the manuscript has been presented elsewhere, in whole or in abstract form as a conference presentation or published material. If no statement is made in this regard, it will be presumed that the authors deny previous publication of the material.

In the case of the use of copyright-protected material the responsibility of obtaining permission is that of the authors.

Disclosure and Conflicts of Interest

Authors are asked to disclose any financial relations and conflicts of interest they may have with a manufacturer or distributor whose product is part of the submitted manuscript. Such interests do not disqualify a paper from consideration and are not disclosed to reviewers. A statement to this effect should be included in the cover letter.

6. Ethical Considerations

An appropriate institutional review board approval is required for experimental investigations of human or animal subjects. Those investigators who do not have formal ethics review committees (institutional or regional) should follow the principles outlined in the Declaration of Helsinki. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the subjects.

Conflicts of Interest

Authors are expected to disclose any commercial associations or sources of support that might pose a conflict of interest regarding the submitted article. All funding sources supporting the work must be declared in the appendix section at the end of the manuscript. Whole affiliations with or financial involvement in any organization on entity with a direct financial interest in the subject matters or materials of the research discussed (examples: employment, consultancies, stock ownership or other equity interest, patent-licensing arrangements) should be cited as conflict of interest at the end of manuscript text file. A reviewer should immediately decline to review an article submitted if he/she feels that the article is technically unqualified or if the timely review cannot be done by him/her or if the article has a conflict of interest. Editors should use ICMJE form and procedure for managing the conflicts of interest issues.

COPE’s Code of Conduct and Best Practices

This journal is committed to follow and apply guidelines of Committee on Publication Ethics (COPE) in its reviewing and publishing process and issues.

1. Editors

Chief Editor is accountable for everything published in the journal. This means the editors

1.1 strive to meet the needs of readers and authors;

1.2 strive to constantly improve their journal;

1.3 have processes in place to assure the quality of the material they publish;

1.4 champion freedom of expression;

1.5 maintain the integrity of the academic record;

1.6 preclude business needs from compromising intellectual and ethical standards;

1.7 are always willing to publish corrections, clarifications, retractions and apologies when needed.

Best Practice for Editors would include

  • actively seeking the views of authors, readers, reviewers and editorial board members about ways of improving their journal’s processes
  • encouraging and being aware of research into peer review and publishing and reassessing their journal’s processes in the light of new findings
  • supporting initiatives designed to reduce research and publication misconduct
  • supporting initiatives to educate researchers about publication ethics
  • assessing the effects of their journal policies on author and reviewer behavior and revising policies, as required, to encourage responsible behavior and discourage misconduct
  • ensuring that any press releases issued by their journal reflect the message of the reported article and put it into context.

2. Readers

2.1 Readers should be informed about who has funded research or other scholarly work and whether the funders had any role in the research and its publication and, if so, what this was.

    Best practice for editors would include:

  • ensuring that all published reports and reviews of research have been reviewed by suitably qualified reviewers including statistical review.
  • ensuring that non-peer-reviewed sections of their journal are clearly identified
  • adopting processes that encourage accuracy, completeness and clarity of research reporting including technical editing and the use of appropriate guidelines and checklists
  • considering developing a transparency policy to encourage maximum disclosure about the provenance of non-research articles
  • adopting authorship or contributorship systems that promote good practice (i.e. so that listings accurately reflect who did the work) and discourage misconduct (e.g. ghost and guest authors)

3. informing readers about steps taken to ensure that submissions from members of the journal’s staff or editorial board receive an objective and unbiased evaluation

4. Relations with authors

4.1 Editors’ decisions to accept or reject a paper for publication should be based on the paper’s importance, originality and clarity, and the study’s validity and its relevance to the remit of the journal.

4.2 Editors should not reverse decisions to accept submissions unless serious problems are identified with the submission.

4.3 New editors should not overturn decisions to publish submissions made by the previous editor unless serious problems are identified.

4.4 A description of peer review processes should be published, and editors should be ready to justify any important deviation from the described processes.

4.5 Journals should have a declared mechanism for authors to appeal against editorial decisions.

4.6 Editors should publish guidance to authors on everything that is expected of them. This guidance should be regularly updated and should refer or link to this code.

4.7 Editors should provide guidance about criteria for authorship and/or who should be listed as a contributor following the standards within the relevant field.

Best practice for editors would include:

  • reviewing author instructions regularly and providing links to relevant guidelines
  • publishing relevant competing interests for all contributors and publishing corrections if competing interests are revealed after publication
  • ensuring that appropriate reviewers are selected for submissions (i.e. individuals who are able to judge the work and are free from disqualifying competing interests)
  • respecting requests from authors that an individual should not review their submission, if these are well-reasoned and practicable
  • publishing details of how they handle cases of suspected misconduct
  • publishing submission and acceptance dates for articles

5. Relations with reviewers

5.1 Editors should provide guidance to reviewers on everything that is expected of them including the need to handle submitted material in confidence. This guidance should be regularly updated and should refer or link to this code.

5.2 Editors should require reviewers to disclose any potential competing interests before agreeing to review a submission.

5.3 Editors should have systems to ensure that peer reviewers’ identities are protected unless they use an open review system that is declared to authors and reviewers.

Best practice for editors would include:

  • encouraging reviewers to comment on ethical questions and possible research and publication misconduct raised by submissions (e.g. unethical research design, insufficient detail on patient consent or protection of research subjects (including animals), inappropriate data manipulation and presentation)
  • encouraging reviewers to comment on the originality of submissions and to be alert to redundant publication and plagiarism
  • considering providing reviewers with tools to detect related publications (e.g. links to cited references and bibliographic searches)
  • sending reviewers’ comments to authors in their entirety unless they contain offensive or libelous remarks
  • seeking to acknowledge the contribution of reviewers to the journal
  • encouraging academic institutions to recognize peer review activities as part of the scholarly process
  • monitoring the performance of peer reviewers and taking steps to ensure this is of high standard
  • developing and maintaining a database of suitable reviewers and updating this on the basis of reviewer performance
  • ceasing to use reviewers who consistently produce discourteous, poor quality or late reviews
  • ensuring that the reviewer database reflects the community for their journal and adding new reviewers as needed
  • using a wide range of sources (not just personal contacts) to identify potential new reviewers (e.g. author suggestions, bibliographic databases)
  • following the COPE flowchart in cases of suspected reviewer misconduct

6. Relations with editorial board members

6.1 Editors should provide new editorial board members with guidelines on everything that is expected of them and should keep existing members updated on new policies and developments.

Best practice for editors would include:

  • having policies in place for handling submissions from editorial board members to ensure unbiased review
  • identifying suitably qualified editorial board members who can actively contribute to the development and good management of the journal
    • regularly reviewing the composition of the editorial board
      • providing clear guidance to editorial board members about their expected functions and duties, which might include:
      • acting as ambassadors for the journal
      • supporting and promoting the journal
      • seeking out the best authors and best work (e.g. from meeting abstracts) and actively encouraging submissions
      • reviewing submissions to the journal
      • accepting commissions to write editorials, reviews and commentaries on papers in their specialist area
      • attending and contributing to editorial board meetings
  • consulting editorial board members periodically (e.g. once a year) to gauge their opinions about the running of the journal, informing them of any changes to journal policies and identifying future challenge

7. Relations with Negah Publisher

7.1 The relationship of editors to Negah Publisher and the owner is based firmly on the principle of editorial independence.

7.2 Editors should make decisions on which articles to publish based on quality and suitability for the journal and without interference from Negah Publisher.

7.3 Editors have a written contract(s) setting out their relationship with Negah Publisher.

7.4 The terms of this contract is in line with the COPE Code of Conduct for Journal Editors.

Best practice for editors would include:

  • communicating regularly with Negah Publisher

8. Editorial and peer review processes

8.1 Editors should strive to ensure that peer review at their journal is fair, unbiased and timely.

8.2 Editors should have systems to ensure that material submitted to their journal remains confidential while under review.

Best practice for editors would include:

  • ensuring that people involved with the editorial process (including themselves) receive adequate training and keep abreast of the latest guidelines, recommendations and evidence about peer review and journal management
  • keeping informed about research into peer review and technological advances
  • adopting peer review methods best suited for their journal and the research community it serves
  • reviewing peer review practices periodically to see if improvement is possible
  • referring troubling cases to COPE, especially when questions arise that are not addressed by the COPE flowcharts, or new types of publication misconduct are suspected
  • considering the appointment of an ombudsperson to adjudicate in complaints that cannot be resolved internally

9. Quality assurance

9.1 Editors should take all reasonable steps to ensure the quality of the material they publish, recognizing that journals and sections within journals will have different aims and standards.

Best practice for editors would include:

  • having systems in place to detect falsified data (e.g. inappropriately manipulated photographic images or plagiarised text) either for routine use or when suspicions are raised
  • basing decisions about journal house style on relevant evidence of factors that raise the quality of reporting (e.g. adopting structured abstracts, applying guidance) rather than simply on aesthetic grounds or personal preference

10. Protecting individual data

10.1 Editors must obey laws on confidentiality in their own jurisdiction. Regardless of local statutes, however, they should always protect the confidentiality of individual information obtained in the course of research or professional interactions. It is therefore almost always necessary to obtain written informed consent for publication from people who might recognize themselves or be identified by others (e.g. from case reports or photographs). It may be possible to publish individual information without explicit consent if public interest considerations outweigh possible harms, it is impossible to obtain consent and a reasonable individual would be unlikely to object to publication.

Best practice for editors would include:

  • publishing their policy on publishing individual data (e.g. identifiable personal details or images) and explaining this clearly to authors

Note that consent to take part in research or undergo treatment is not the same as consent to publish personal details, images or quotations.

11. Encouraging ethical research (e.g. research involving humans or animals)

11.1 Editors should endeavour to ensure that research they publish was carried out according to the relevant internationally Declaration of Helsinki for clinical research, and the AERA and BERA guidelines for educational research.

11.2 Editors should seek assurances that all research has been approved by an appropriate body (e.g. research ethics committee, institutional review board) where one exists. However, editors should recognize that such approval does not guarantee that the research is ethical.

Best practice for editors would include:

  • being prepared to request evidence of ethical research approval and to question authors about ethical aspects (such as how research participant consent was obtained or what methods were employed to minimize animal suffering) if concerns are raised or clarifications are needed
  • ensuring that reports of clinical trials cite compliance with the Declaration of Helsinki, Good Clinical Practice.
  • appointing a journal ethics advisor or panel to advise on specific cases and review journal policies periodically

12. Dealing with possible misconduct

12.1 Editors have a duty to act if they suspect misconduct or if an allegation of misconduct is brought to them. This duty extends to both published and unpublished papers.

12.2 Editors should not simply reject papers that raise concerns about possible misconduct. They are ethically obliged to pursue alleged cases.

12.3 Editors should follow the COPE flowcharts where applicable.

12.4 Editors should first seek a response from those suspected of misconduct. If they are not satisfied with the response, they should ask the relevant employers, or institution, or some appropriate body (perhaps a regulatory body or national research integrity organization) to investigate.

12.5 Editors should make all reasonable efforts to ensure that a proper investigation into alleged misconduct is conducted; if this does not happen, editors should make all reasonable attempts to persist in obtaining a resolution to the problem. This is an onerous but important duty.

13. Ensuring the integrity of the academic record

13.1 Errors, inaccurate or misleading statements must be corrected promptly and with due prominence.

13.2 Editors should follow the COPE guidelines on retractions.

Best practice for editors would include:

  • taking steps to reduce covert redundant publication (e.g. by requiring all clinical trials to be registered)
  • ensuring that published material is securely archived (e.g. via online permanent repositories, such as PubMed Central)
  • having systems in place to give authors the opportunity to make original research articles freely available

14. Intellectual property

14.1 Editors should be alert to intellectual property issues and work with Negah Publisher to handle potential breaches of intellectual property laws and conventions.

Best practice for editors would include:

  • adopting systems for detecting plagiarism (e.g. software, searching for similar titles) in submitted items (either routinely or when suspicions are raised)
  • supporting authors whose copyright has been breached or who have been the victims of plagiarism
  • being prepared to work with Negah Publisher to defend authors’ rights and pursue offenders (e.g.  by requesting retractions or removal of material from websites) irrespective of whether their journal holds the copyright

15. Encouraging debate

15.1 Editors should encourage and be willing to consider cogent criticisms of work published in their journal.

15.2 Authors of criticized material should be given the opportunity to respond.

15.3 Studies reporting negative results should not be excluded.

Best practice for editors would include:

  • being open to research that challenges previous work published in the journal

16. Complaints

16.1 Editors should respond promptly to complaints and should ensure there is a way for dissatisfied complainants to take complaints further. This mechanism should be made clear in the journal and should include information on how to refer unresolved matters to COPE.

16.2 Editors should follow the procedure set out in the COPE flowchart on complaints.

17. Commercial considerations

17.1 Journals should have policies and systems in place to ensure that commercial considerations do not affect editorial decisions (e.g. advertising departments should operate independently from editorial departments).

17.2 Editors should have declared policies on advertising in relation to the content of the journal and on processes for publishing sponsored supplements.

17.3 Reprints should be published as they appear in the journal unless a correction needs to be included in which case it should be clearly identified.

Best practice for editors would include:

  • publishing a general description of their journal’s income sources (e.g. the proportions received from display advertising, reprint sales, sponsored supplements, page charges, etc.)
  • ensuring that the peer review process for sponsored supplements is the same as that used for the main journal
  • ensuring that items in sponsored supplements are accepted solely on the basis of academic merit and interest to readers and decisions about such supplements are not influenced by commercial considerations

 7. Plagiarism check

This Journal has accepted all terms and conditions of Committee on Publication Ethics (COPE) on plagiarism. Therefore, in any case of plagiarism, which is brought to the journal’s editors attention and accompanied with convincing evidence, we act based on flowcharts and workflows determined in COPE. Meanwhile, to detect and prevent plagiarism in the journal articles, all submissions will be checked with Anti-Plagiarism Paper Check in both stages of submission and acceptance.

8. Submission

Submission can be pursued electronically only through the website. This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. To partly cover the publication expenses, there is a submission fee for original and review manuscripts. The submission fee is 12.000.000 Iranian Rials (80 US$).

9. Peer Review Process

All submissions are considered to be confidential and are peer-reviewed by at least 2 anonymous experts in the related field selected by the editors. The corresponding author is notified as soon as possible of the editor's decision to accept or reject the manuscript, or whether it requires modifications.

Each accepted manuscript is edited so that its message is clear and conforms to the style of the journal. The core of the contents is edited to the standards of the journal. Before publication, authors receive page proofs for minor corrections.

 

 

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than
  5. Manuscript preparation:

    1- Summary (for busy authors)

    Title page, Including title of the article, authors' names, affiliations, and detailed information of corresponding authors; Phone and Fax number, Email, and Postal Address should be supplied and submitted as a separate file.

    Manuscript text file should be prepared according to specific research reporting guidelines (See table). In addition, Appendix section including acknowledgment, funding, and authors' contribution, should be addressed at the end of the manuscript text in all types of the above-mentioned articles. All clinical trials should be registered in a registry of clinical trials approved by the World Health Organization (WHO) or the International Committee of Medical Journal Editors (ICMJE). As an option, the Iranian Registry of Clinical Trials (IRCT) is one of the suggested registries .

    Table: Standard Reporting Guidelines

    Type of study
    Guideline
    Clinical Trials
    Observational
    Systematic reviews and meta-analysis on clinical trials
    Meta-analysis of observational studies
    Diagnostic accuracy
    Qualitative research
    Others
     
  6. 2- Details

    The journal adheres to the recommendations of International Committee of Medical Journal Editors (ICMJE). The main manuscript should carry the title, abstract, main text, acknowledgment, funding, authors' contribution, references, figures, and tables of the paper. The preferred word processing format for the manuscript file is Microsoft Word version 2003 or newer. Manuscripts should be double-spaced, with 2.5 cm margins on all sides. All abbreviations must be spelled out the first time used, followed by the abbreviated form in parentheses. Units of measurement must be complied with the International System of Units (SI). For indexing, three to five key words should be typed at the end of the abstract for each manuscript. These words should be identical to the medical subject headings (MeSH) that appear in the Index Medicus of the National Library of Medicine.

    Observational Studies

    Cohort, case control, and cross-sectional studies should be arranged based on Strengthening the Reporting of Observational studies in Epidemiology (STORBE) statement and checklist as: Abstract, Keywords, Introduction, Methods, Results, Discussion, Conclusion, Acknowledgements, References, Tables, and Figures. A structured abstract (with the subheadings title, introduction, methods, results, and conclusion) should appear on the first page of the manuscript and should not exceed 350 words. The main text (excluding the abstract and references) should not exceed 3500 words.

    Clinical Trials

    Original research papers that report a randomized controlled trial, should comply with the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) group. Also, supplying the manuscript with a CONSORT flowchart diagram is highly encouraged. Researchers who would like to publish their clinical trial reports in Emergency are strongly encouraged to register their studies in a registry of clinical trials, which meets the criteria of WHO or ICMJE. As an option, the Iranian Registry of Clinical Trials (IRCT) is a registry suggested by WHO.

    Reviews

    Review articles should be composed of systematic critical assessments of literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. They should have unstructured abstracts. All articles and data sources should include information about the specific types of study or analysis, population, intervention, exposure, and tests or outcomes. Authors of review articles should be expert and have contributions in the field of the addressed subject. Systematic reviews and meta-analyses on clinical trials and observational studies should be prepared based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analysis of observational studies in epidemiology (MOOSE), respectively.

    Case Reports

    Case reports should be arranged as follows: Abstract (unstructured, not exceeding 200 words), Introduction, Case Report, Discussion, References, and Figures. The length should not exceed 1000 words.

    Brief Reports

    Original research papers can also be published in a brief format. Submitted papers that are of interest but not acceptable as a full-length original/reaserch article, are offered by the editor to be published in this section. The authors can also primarily submit their papers for consideration of publication in this section. An unstructured abstract no longer than 200 words is required for this section. The body of the manuscript should not exceed 2000 words, and no heading or subheading should be used. The number of tables and/or figures should be limited to 2 and references to a maximum of 15.

    Letters to the Editor

    All correspondence will be considered for publication if it contains constructive criticism on previously published articles in Emergency, the authors of which will have the right of reply. Also, reports of limited research or clinical experiences can be submitted in the form of a letter. The length should not exceed 700 words.

    Photo Quiz

    Photo quiz should be arranged as follows: patient's imaging(s), brief case presentation followed by a question as “what is your diagnosis”, diagnosis, and discussion. It may be up to 1500 words. The maximum number of imagings is six. Number of references should not exceed ten.

    Appendix:

    Conflict of Interest

    Authors are expected to disclose any commercial associations or sources of support that might pose a conflict of interest regarding the submitted article. All funding sources supporting the work must be declared in the appendix section at the end of the manuscript. Whole affiliations with or financial involvement in any organization on entity with a direct financial interest in the subject matters or materials of the research discussed (examples: employment, consultancies, stock ownership or other equity interest, patent-licensing arrangements) should be cited as conflict of interest at the end of manuscript text file.

    Authorship

    Based on the ICJME recommendations "all those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged".

     
 

Copyright Notice

The authors transfer all copyright ownership of the manuscript to the Social Determinants of health Research Center in the event the work is published. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work, with an acknowledgement of its initial publication in this journal.

 

LICENSING

As part of our commitment to the widest-possible distribution of scientific literature, we have embraced the CC BY-NC licenses for the work that we publish. This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.